Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Поясничная боль: возможности применения структурно-модифицирующих препаратов
Поясничная боль: возможности применения структурно-модифицирующих препаратов
Камчатнов П.Р., Евзельман М.А. Поясничная боль: возможности применения структурно-модифицирующих препаратов. Consilium Medicum. 2014; 16 (9): 36–40.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Алексеев В.В. Хондропротекторы в неврологии: основания к применению. Cons. Med. 2012; 14; 9: 94–9.
2. Алексеева Л.И., Чичасова Н.В., Мендель О.И. Рациональный выбор базисной терапии при остеоартрозе. Результаты открытого рандомизированного многоцентрового исследования препарата Артра в России. РМЖ. Ревматология. 2005; 24 (13): 1636–41.
3. Алексенко Е.Ю., Говорин А.В. Изменение показателей липидов и цитокинов крови у больных первичным остеоартрозом на фоне лечения препаратом Артра. Научно-практическая ревматология. 2011; 3: 37–40.
4. Бадокин В.В. Пути оптимизации терапии остеоартроза. Arta Medica 2007; 5 (26): 55–61.
5. Никифоров А.С., Авакян Г.Н. Неврологические осложнения остеохондроза позвоночника. М.: Медпрактика-М, 2011.
6. Чебыкин А.В. Опыт применения хондропротектора Артра у пациентов с болью в спине. Неврология, нейропсихиатрия, психосоматика. 2012; 3: 67–72.
7. Borenstein D. Does osteoarthritis of the lumbar spine cause chronic low back pain? Curr Pain Headache Rep 2004; 8: 512–7.
8. Hagen K, Jamtvedt G, Hilde G, Winnem M. Bed rest bad for back pain, ineffective for sciatica. The updated Cochrane Review of bed rest for low back pain and sciatica. Spine 2005; 30: 542–46.
9. Hall H, McIntosh G. Low back pain (acute). Clin Evid 2008;
p. 1102–8.
10. Helin-Salmivaara A, Saarelainen S, Gro Nroos J et al. Risk of upper gastrointestinal events with the use of various NSAIDs: A case-control study in a general population. Scand J Gastroenterol 2007; 42: 923–32.
11. Huskinsson E, Berry P, Gishen P. Effects of anti-inflammatory drugs on the progression of osteoarthritis of the knee. J Rheumatol 1995; 22: 1941–6.
12. Jordan K, Arden N, Doherty M et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Nrials (ESCISIT). Ann Rheum Dis 2003; 62: 1145–55.
13. Kim T, Montejano L, Cao Z, Zhao Y. Health care costs in US patients with and without a diagnosis of osteoarthritis. J Pain Research 2012; 5: 23–30.
14. Leffler C, Philippi A, Leffler S еt al. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med 1999; 164 (2): 85–91.
15. Lippielo L, Woodword J, Karpman D еt al. Beneficial effect of cartilage structure modyifing agents tested in chondrocyte and rabbit instability model osteoartrosis. Arthr Rheum 1999; 42: 256.
16. Lippielo L, Grande D. In vitro chondroprotection of glucosamine and chondroitin sulfate in a rabbit model of a OA and demonstration of metabolic synergy on chondrocyte in vitro. Ann Rheum Dis 2000; 59 (Suppl. 1): 266.
17. Michel B, Bruhlmann P, Stucki G, Uebelhart D. Chondroprotection through Chondrosulf: the Zurich study. Ann Rheum Dis 2002; 61 (Suppl. 1): 116.
18. Pelletier J-P. Comprehensive Strategies for the Treatment of Osteoarthritis Targeting Both Symptoms and Structural Changes. Eur Musculoscel Rev Osteoarthritis EULAR 2009; p. 20–24.
19. Register J, Rovati L, Deroisy R. Glucosamine sulfate slows-down osteoarthritis progression in postmenopausal women: pooled analysis of two large, independent randomized, placebo-controlled, double-blind, prospective 3-year trials. Ann Rheum Dis 2002; 61 (Suppl. 1): THU0196.
20. Schneider S, Schmitt H, Zoller S, Schiltenwolf M. Workplace stress, lifestyle and social factors as correlates of back pain: a representative study of the German working population. Int Arch Occup Environ Health 2005; 78 (4): 253–69.
21. Sharma H, Gupta R, Olivero W et al. fMRI in patients with lumbar disc disease: a paradigm to study patients over time. J Pain Research 2011; 4: 401–5.
22. Singh G, Alekseeva L, Alekseev V, Triadafilopoulos G. Glucosamine-chondroitin sulfate reduces pain, disability and said consumption in patients with chronic low back pain: a large, community-based, pilot, open prospective observational study. SAT0419.
23. The efficacy of Glucosamine and Chondroitin Sulfate in Patients with Painful Knee Osteoarthritis (OA): The Glucosamine/chondroitin Arthritis Intervention Trial (GAIT). 2005 ACR/ARHP Annual Sciehtific Meeting, November 12–17. San Diego, California 622.
24. van Tulder M, Becker A, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006; 15 (Suppl. 2): s169–91.
25. Wilkens P, Scheel I, Grundnes O et al. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial.
JAMA 2010; 304 (1): 45–52.
2. Алексеева Л.И., Чичасова Н.В., Мендель О.И. Рациональный выбор базисной терапии при остеоартрозе. Результаты открытого рандомизированного многоцентрового исследования препарата Артра в России. РМЖ. Ревматология. 2005; 24 (13): 1636–41.
3. Алексенко Е.Ю., Говорин А.В. Изменение показателей липидов и цитокинов крови у больных первичным остеоартрозом на фоне лечения препаратом Артра. Научно-практическая ревматология. 2011; 3: 37–40.
4. Бадокин В.В. Пути оптимизации терапии остеоартроза. Arta Medica 2007; 5 (26): 55–61.
5. Никифоров А.С., Авакян Г.Н. Неврологические осложнения остеохондроза позвоночника. М.: Медпрактика-М, 2011.
6. Чебыкин А.В. Опыт применения хондропротектора Артра у пациентов с болью в спине. Неврология, нейропсихиатрия, психосоматика. 2012; 3: 67–72.
7. Borenstein D. Does osteoarthritis of the lumbar spine cause chronic low back pain? Curr Pain Headache Rep 2004; 8: 512–7.
8. Hagen K, Jamtvedt G, Hilde G, Winnem M. Bed rest bad for back pain, ineffective for sciatica. The updated Cochrane Review of bed rest for low back pain and sciatica. Spine 2005; 30: 542–46.
9. Hall H, McIntosh G. Low back pain (acute). Clin Evid 2008;
p. 1102–8.
10. Helin-Salmivaara A, Saarelainen S, Gro Nroos J et al. Risk of upper gastrointestinal events with the use of various NSAIDs: A case-control study in a general population. Scand J Gastroenterol 2007; 42: 923–32.
11. Huskinsson E, Berry P, Gishen P. Effects of anti-inflammatory drugs on the progression of osteoarthritis of the knee. J Rheumatol 1995; 22: 1941–6.
12. Jordan K, Arden N, Doherty M et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Nrials (ESCISIT). Ann Rheum Dis 2003; 62: 1145–55.
13. Kim T, Montejano L, Cao Z, Zhao Y. Health care costs in US patients with and without a diagnosis of osteoarthritis. J Pain Research 2012; 5: 23–30.
14. Leffler C, Philippi A, Leffler S еt al. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med 1999; 164 (2): 85–91.
15. Lippielo L, Woodword J, Karpman D еt al. Beneficial effect of cartilage structure modyifing agents tested in chondrocyte and rabbit instability model osteoartrosis. Arthr Rheum 1999; 42: 256.
16. Lippielo L, Grande D. In vitro chondroprotection of glucosamine and chondroitin sulfate in a rabbit model of a OA and demonstration of metabolic synergy on chondrocyte in vitro. Ann Rheum Dis 2000; 59 (Suppl. 1): 266.
17. Michel B, Bruhlmann P, Stucki G, Uebelhart D. Chondroprotection through Chondrosulf: the Zurich study. Ann Rheum Dis 2002; 61 (Suppl. 1): 116.
18. Pelletier J-P. Comprehensive Strategies for the Treatment of Osteoarthritis Targeting Both Symptoms and Structural Changes. Eur Musculoscel Rev Osteoarthritis EULAR 2009; p. 20–24.
19. Register J, Rovati L, Deroisy R. Glucosamine sulfate slows-down osteoarthritis progression in postmenopausal women: pooled analysis of two large, independent randomized, placebo-controlled, double-blind, prospective 3-year trials. Ann Rheum Dis 2002; 61 (Suppl. 1): THU0196.
20. Schneider S, Schmitt H, Zoller S, Schiltenwolf M. Workplace stress, lifestyle and social factors as correlates of back pain: a representative study of the German working population. Int Arch Occup Environ Health 2005; 78 (4): 253–69.
21. Sharma H, Gupta R, Olivero W et al. fMRI in patients with lumbar disc disease: a paradigm to study patients over time. J Pain Research 2011; 4: 401–5.
22. Singh G, Alekseeva L, Alekseev V, Triadafilopoulos G. Glucosamine-chondroitin sulfate reduces pain, disability and said consumption in patients with chronic low back pain: a large, community-based, pilot, open prospective observational study. SAT0419.
23. The efficacy of Glucosamine and Chondroitin Sulfate in Patients with Painful Knee Osteoarthritis (OA): The Glucosamine/chondroitin Arthritis Intervention Trial (GAIT). 2005 ACR/ARHP Annual Sciehtific Meeting, November 12–17. San Diego, California 622.
24. van Tulder M, Becker A, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006; 15 (Suppl. 2): s169–91.
25. Wilkens P, Scheel I, Grundnes O et al. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial.
JAMA 2010; 304 (1): 45–52.
Авторы
П.Р.Камчатнов1, М.А.Евзельман2
1. ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздрава России, Москва;
2. ГБОУ ВПО Орловский государственный университет
1. ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздрава России, Москва;
2. ГБОУ ВПО Орловский государственный университет
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.